Approval · Notice of Compliance 35632 · 2025
TOBREX: Notice of Compliance 35632
Issued July 4, 2025
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 35632
- Date
- July 4, 2025
- Company
- Novartis Pharmaceuticals Canada Inc.Montreal, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Change in the specification for the drug product
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| TOBREX | Not yet assigned | — |
Medicinal ingredients
- TOBRAMYCIN 0.3 PER